In the context of rapid development of nanoparticles (NPs) for industrial applications, the question of their toxicity and biological effects must be considered. In this work, we have assessed the influence of titanium dioxide NPs on the adhesion and spreading of MC-3T3 pre-osteoblasts by using a cell subclone that does not produce its own extracellular matrix. Petri dishes were coated with the important adhesion protein fibronectin (Fn). By incubating these Fn-coated surfaces with different amounts of TiO(2) NPs, we have shown that the adhesion of pre-osteoblasts is disturbed, with an important decrease in the number of adherent cells (from 40 to 75% depending upon the concentration and type of NPs). Petri-dish surfaces were analyzed with environmental scanning electron microscropy (ESEM), with images showing that TiO(2) NP aggregates are bound to the layer of adsorbed Fn molecules. The cells cultured on these Fn/NP surfaces adopted an irregular shape and an aberrant organization of actin cytoskeleton, as revealed by fluorescence microscopy. Most importantly, these results, taken together, have revealed that the actin cytoskeleton forms abnormal aggregates, even on top of the nucleus, that coincide with the presence of large aggregates of NPs on top of cells. On the basis of these observations, we propose that some Fn molecules are able to desorb from the Petri dish surface to coat TiO(2) NPs. Fn/NP complexes are not attached firmly enough on the surface to allow for normal cell adhesion/spreading and the development of tense actin fibers. These results stress the paramount need for the assessment of the toxicology of NPs, with special attention to their interactions with biomolecules.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.